F Kiessling Selected Research

Neoplasms (Cancer)

1/2019	Dual CTLA-4 and PD-L1 Blockade Inhibits Tumor Growth and Liver Metastasis in a Highly Aggressive Orthotopic Mouse Model of Colon Cancer.
11/2015	[Molecular ultrasound imaging: Clinical applications].
10/2015	Applications of nanoparticles for diagnosis and therapy of cancer.
3/2015	Formulation and characterization of microspheres loaded with imatinib for sustained delivery.
1/2014	In vitro, in vivo and in silico analysis of the anticancer and estrogen-like activity of guava leaf extracts.
3/2012	Imaging in the age of molecular medicine: monitoring of anti-angiogenic treatments.
2/2009	TNF-alpha and the IFN-gamma-inducible protein 10 (IP-10/CXCL-10) delivered by parvoviral vectors act in synergy to induce antitumor effects in mouse glioblastoma.
9/2008	Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy.
7/2007	Initial Experience with a Novel Low-Dose Micro-CT System.
1/2007	Contrast agents and applications to assess tumor angiogenesis in vivo by magnetic resonance imaging.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

F Kiessling Research Topics

Disease

12	Neoplasms (Cancer) 01/2019 - 04/2002
3	Carcinoma (Carcinomatosis) 09/2008 - 06/2003
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Inflammation (Inflammations) 11/2015
1	Glioblastoma (Glioblastoma Multiforme) 02/2009
1	Glioma (Gliomas) 02/2009
1	Vascular Diseases (Vascular Disease) 01/2009
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2009
1	Body Weight (Weight, Body) 07/2003
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2002

Drug/Important Bio-Agent (IBA)

3	Contrast MediaIBA 11/2015 - 04/2002
3	Gadolinium DTPA (Magnevist)FDA Link 07/2003 - 06/2003
2	Pharmaceutical PreparationsIBA 01/2014 - 04/2002
2	Biomarkers (Surrogate Marker)IBA 01/2009 - 01/2007
1	CollagenIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Interleukin-4 (Interleukin 4)IBA 01/2019
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 11/2015
1	Imatinib Mesylate (Gleevec)FDA Link 03/2015
1	Estrogen ReceptorsIBA 01/2014
1	Selective Estrogen Receptor Modulators (SERM)IBA 01/2014
1	guajadialIBA 01/2014
1	psidial AIBA 01/2014
1	Tamoxifen FDA LinkGeneric 01/2014
1	Proteins (Proteins, Gene)FDA Link 02/2009
1	CytokinesIBA 02/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2009
1	Therapeutic UsesIBA 02/2009
1	E-SelectinIBA 01/2009
1	IntegrinsIBA 01/2009
1	hydroxypropyl methacrylateIBA 09/2008
1	Gemcitabine FDA Link 09/2008
1	N-(2-hydroxypropyl)methacrylamideIBA 09/2008
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2008
1	Angiogenesis InhibitorsIBA 01/2007
1	Protons (Proton)IBA 06/2003
1	LipidsIBA 06/2003
1	AlbuminsIBA 04/2002
1	Blood Proteins (Serum Proteins)IBA 04/2002

Therapy/Procedure

5	Therapeutics 10/2015 - 04/2002
1	Microspheres (Microsphere) 03/2015
1	Chemoradiotherapy 09/2008
1	Stents 07/2007